The Practical Technical Aspects of Slow Continuous Ultrafil Tration (SCUF) and Continuous Arteriovenous Hemofiltration (CAVH)

  • S. Swann
  • E. Paganini
Part of the Developments in Nephrology book series (DINE, volume 13)


Slow continuous ultrafiltration (SCUF) and continuous arteriovenous hemofiltration (CAVH) have been utilized at The Cleveland Clinic Foundation, Department of Hypertension and Nephrology since 1977 in over 150 patients as a clinical therapy for the treatment of acute renal failure.

The purpose of this chapter is to instruct and educate the medical personnel in direct contact with patients who require SCUF and/or CAVH with regard to the practical set-up, monitoring, and management of this continuous renal replacement therapy. This includes the general description and design of the extracorporeal circuit, including suggestions for successful operation and management for the on-going monitoring and regimen involved in this therapy to provide an easy, simple, yet effective outline of practical “how to” description of operation. In order to provide optimal results and benefit to the patient undergoing SCUF or CAVH a technical description and understanding is essential for the success of this modality of treatment.


Continuous Renal Replacement Therapy Extracorporeal Circuit Ultrafiltration Rate Dialysis Machine Blood Line 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Paganini EP, Nakamoto S: Continuous slow ultrafiltration in oliguric acute renal failure. Trans Am Soc Artif Intern Organs 26:201, 1980.PubMedGoogle Scholar
  2. 2.
    Kramer P, Buhler J, Kehr A, et al: Intensive care potential of CAVH. Trans Am Soc Artif Intern Organs 28:28, 1982.PubMedGoogle Scholar
  3. 3.
    Amicon Corp., Danvers, MA, 01923. Amicon Models 20 & 30 hemofilters & A-V blood lines.Google Scholar
  4. 4.
    Gambro Inc., Barrington, IL, 60010. Ref. for FH-55 hemofilters & A-V blood lines.Google Scholar
  5. 5.
    Hospal Med Corp., E. Brunswick, NJ, 08816. Ref for Biospal 1200 S Plate Dialyzer used for SCOF/CAVH & A-V blood tubing sets.Google Scholar
  6. 6.
    Castro LA, Banthien F, Gurland HJ: Successful clinical experience in use of small filter sheet dialyzer for CAVH.Google Scholar
  7. 7.
    Lifemed Corp., Ref. for A-V blood tubing sets for SCUF/CAVH, Compton CA, 90220.Google Scholar
  8. 8.
    International Technidyne Corp., Metuchen, NJ, 08840. Ref. for Hemochron 400 for activated clotting time control.Google Scholar
  9. 9.
    Vitalmetrics Inc., San Diego, CA, 92121. Ref for Electronic digital urinary monitoring system.Google Scholar
  10. 10.
    Travenol Labs, Deerfield IL, 60015. Ref for CAVH replacement solution kits.Google Scholar
  11. 11.
    Schriever HG, Epstein SE, Mintz MD: Statistical correlation and heparin sensitivity of activated PTT, whole blood coagulation time, and an automated coagulation time. Am J Clin Path 60(3): 323–329, 1973.PubMedGoogle Scholar
  12. 12.
    Shanillin N, Ploth DW: Evaluation of an activated clotting time technique for use in hemodialysis. Dial Transpl 9(10): 955–957, 1980.Google Scholar
  13. 13.
    Kramer P, Wigger W, Rieger J, et al: Ar teriovenous hemofiltration: A new and simple method of treating overhydrated patients resistant to diuretics. Klin Wschr 55:1121, 1977.PubMedCrossRefGoogle Scholar
  14. 14.
    Seldinger SI: Catheter replacement of the needle in percutaneous arteriography. Acta Radiol (Stockh) 20:368–376, 1939.Google Scholar
  15. 15.
    Shaldon S, Chiandussi L, Higgs B: Hemodialysis by percutaneous catheterization of the femoral artery and vein with regional heparinization. Lancet 2:857–859, 1961.CrossRefGoogle Scholar
  16. 16.
    Brescia MJ, Cimino JE, Appel K, Hurwich BJ: Chronic dialysis using venipuncture and surgically created arteriovenous fistula. N Engl J Med 275:1089–1092, 1966.PubMedCrossRefGoogle Scholar
  17. 17.
    Wellington JL: Expanded polytetrafluoroethylene prosthetic grafts for blood access in patients on dialysis. Surgery 21:42–422, 1978.Google Scholar
  18. 18.
    Cohen PG: Circulatory access for extracorporeal blood modification. Plasma Therapy 2:235, 1982.Google Scholar
  19. 19.
    Kaye W: Invasive monitoring techniques: Arterial can-nulation, bedside pulmonary artery catheterization, and arterial puncture. Heart Lung 12:395, 1983.PubMedGoogle Scholar
  20. 20.
    Grone HJ, Kramer P: Puncture and long term cannulation of the femoral artery and vein in adults in continuous arterio-venous hemofiltration. Vandenhoeck & Ruprecht, 1982.Google Scholar
  21. 21.
    Ulbricht C, Schnrek HJ, Tytul S, et al: Efficacy of CAVH in acute renal failure influence of blood pressure, blood flow, vascular access, and filter type, (abstract). Blood Purification 2:57, 1984.Google Scholar
  22. 22.
    Lauer A, Saccaggi A, Ronco C, et al: Continuous arteriovenous hemofiltration in the critically ill patient. Ann Intern Med 99:450, 1983.Google Scholar
  23. 23.
    Paganini EP: Unpublished data.Google Scholar

Copyright information

© Martinus Nijhoff Publishing 1986

Authors and Affiliations

  • S. Swann
    • 1
  • E. Paganini
    • 1
  1. 1.The Cleveland Clinic FoundationClevelandUSA

Personalised recommendations